Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nolan J O'Connor

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ACS Synthetic Biology|September 19, 2019
Construction of Two-Input Logic Gates Using Transcriptional InterferenceAntoni E Bordoy, Nolan J O'Connor, Anushree Chatterjee
ACS Synthetic Biology|March 12, 2021
Engineering Transcriptional Interference through RNA Polymerase Processivity ControlNolan J O'Connor, Antoni E Bordoy, Anushree Chatterjee
ACS Biomaterials Science & Engineering|February 28, 2023
Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19Colleen R McCollum, Colleen M Courtney, Nolan J O'Connor, et al.
ACS Biomaterials Science & Engineering|June 21, 2022
Nanoligomers Targeting Human miRNA for the Treatment of Severe COVID-19 Are Safe and Nontoxic in MiceColleen R McCollum, Colleen M Courtney, Nolan J O'Connor, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ACS Synthetic Biology|September 19, 2019
Construction of Two-Input Logic Gates Using Transcriptional InterferenceAntoni E Bordoy, Nolan J O'Connor, Anushree Chatterjee
ACS Synthetic Biology|March 12, 2021
Engineering Transcriptional Interference through RNA Polymerase Processivity ControlNolan J O'Connor, Antoni E Bordoy, Anushree Chatterjee
ACS Biomaterials Science & Engineering|February 28, 2023
Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19Colleen R McCollum, Colleen M Courtney, Nolan J O'Connor, et al.
ACS Biomaterials Science & Engineering|June 21, 2022
Nanoligomers Targeting Human miRNA for the Treatment of Severe COVID-19 Are Safe and Nontoxic in MiceColleen R McCollum, Colleen M Courtney, Nolan J O'Connor, et al.
Pageof 1